china is a big country in the production and consumption of skin care products. in recent years, with the improvement of the national income level and the upgrading of consumption concepts, the market size of skin care products has expanded significantly, and the competition in the industry has become increasingly fierce. at a time when new brands, new effects, and new ingredients are constantly emerging, consumers pay special attention to the safety of product ingredients and the authenticity of their effects. the state food and drug administration's inspection and supervision of endless skin care products on the market is also increasing year by year.
with the increasingly strict requirements of the eu cosmetic regulations on the prohibition of laboratory animals, banned and restricted substances and microorganisms in cosmetics, and the continuous promotion of the 3r (replace, optimize, and reduce) principles of laboratory animal ethics, the reduction and cancellation of cosmetic animal testing for safety evaluation has been more and more countries recognized.
noa provides cosmetics safety and efficacy evaluation services for enterprises based on new technologies such as cell culture, tissue engineering and systems biology with professional testing capabilities and a first-class in vitro efficacy testing platform. at the same time, noa can provide one-stop targeted solutions according to the specific needs of enterprises, helping enterprises to develop and innovate.
1. in vitro efficacy testing
project name |
method |
moisture |
detection of aquaporin-3 (a qp3) expression in vivo |
hyaluronic acid content in the body (cells) |
|
3d epidermis model moisturizing test |
|
crease resistant |
collagen protein enzyme inhibition (biochemical) |
efficacy detection of mmp i protein inhibition |
|
detection of free radical scavenging capacity such as dpph (biochemical) |
|
mitochondrial membrane potential detection (cell) |
|
detection of reactive oxygen species (ros) clearance capacity in keratinocytes |
|
fibroblast type i collagen promotes efficacy detection |
|
compact |
elastase inhibition (biochemical) |
detection of free radical scavenging capacity such as dpph (biochemical) |
|
detection of reactive oxygen species (ros) clearance capacity in keratinocytes |
|
elastin generation (cell) |
|
leisurely |
hyaluronidase inhibition (biochemical) |
efficacy of tnf α |
|
inflammatory factor inhibition (double factor) (cell) |
|
in vitro degranulation detection of mast cells |
|
tdetection of trpv1 receptor inhibition efficacy |
|
temperate no stimulation |
keratin cytotoxicity assays |
detection of het-cam eye irritation in chick embryo |
|
rabbit corneal epithelial cells (sirc) eye irritation detection |
|
eye irritation test in the 3d corneal model |
|
3d epidermal cell model |
|
oil-control |
5- α reductase inhibition (biochemical) |
detection of the oil-control efficacy of s z95 sebaceous gland cells |
|
anti-dangdruff |
malassezia species, the antibacterial rate |
whitening |
detection of the whitening efficacy of in vitro recombinant 3d melanin model |
b 16 melanocytic internal melanin inhibition assay |
|
detection of tyrosinase activity inhibition efficacy (biochemical) |
tel: 86-400 821 5138
fax: 86-21 3327 5843
email:noa@noagroup.com